Peggy Terzaghi-Howe

Title: Peggy Terzaghi-Howe: Innovator in Anti-Tumor Bacterial Preparations

Introduction

Peggy Terzaghi-Howe is a notable inventor based in Montrose, CO (US). She has made significant contributions to the field of biotechnology, particularly in the development of bacterial preparations with anti-tumor activity. Her innovative work has the potential to impact cancer treatment methodologies.

Latest Patents

Peggy holds a patent for a gamma-irradiated bacterial preparation that exhibits anti-tumor activity. This preparation is derived from a Pseudomonas species isolated as #15 ATCC 55638. The process involves exposing the bacterial suspension to gamma radiation, which results in cytotoxicity specifically targeting neoplastic carcinoma cells. Additionally, her patent describes a method for obtaining a bacterial preparation with anti-reverse transcriptase activity from an amoeba-associated bacterial isolate grown to stationary phase.

Career Highlights

Peggy Terzaghi-Howe is associated with Lockheed Martin Energy Research Corporation, where she has been able to apply her expertise in microbiology and cancer research. Her work has garnered attention for its innovative approach to utilizing bacterial preparations in therapeutic applications.

Collaborations

Throughout her career, Peggy has collaborated with esteemed colleagues such as Arpad Alexander Vass and Richard L Tyndall. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Peggy Terzaghi-Howe's contributions to the field of anti-tumor bacterial preparations highlight her innovative spirit and dedication to advancing cancer treatment. Her work continues to inspire future research in biotechnology and therapeutic applications.